HCID 57937544, compound → Methyl 3-hydroxy-5-[5-(5-methyl-1,3,4-oxadiazol-2-yl)-1H-benzimidazol-1-yl]-2-thiophenecarboxylate
Reaction equation
ClC1C=CC=CC=1[C@H]([O:10][C:11]1[CH:15]=[C:14]([N:16]2[C:20]3[CH:21]=[CH:22][C:23]([C:25]4[O:26][C:27]([CH3:30])=[N:28][N:29]=4)=[CH:24][C:19]=3[N:18]=[CH:17]2)[S:13][C:12]=1[C:31]([O:33][CH3:34])=[O:32])C.ClC1C(O)=CC=CC=1[C@H](OC1C=C(N2C3C=C(C#N)C=CC=3N=C2)SC=1C(OC)=O)C>>[OH:10][C:11]1[CH:15]=[C:14]([N:16]2[C:20]3[CH:21]=[CH:22][C:23]([C:25]4[O:26][C:27]([CH3:30])=[N:28][N:29]=4)=[CH:24][C:19]=3[N:18]=[CH:17]2)[S:13][C:12]=1[C:31]([O:33][CH3:34])=[O:32]Participants
3
Procedure
The title compound was prepared from methyl 3-{[(1R)-1-(2-chlorophenyl) ethyl]oxy}-5-[5-(5-methyl-1,3,4-oxadiazol-2-yl)-1H-benzimidazol-1-yl]-2-thiophenecarboxylate (139 mg) using a procedure analogous to Intermediate 3, Step D to give 82.0 mg of the desired product. MS (ESI): 357 [M+H]+.
Sources & evidence
- ORD record
- ord-dc46d7c7336c4875b752f60ecfd8f67d
- Source dataset
- uspto-grants-2009_11
- Patent number
- US07615643B2
Reaction notes
Loading…